Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains
By Will Feuer
Elevance Health issued upbeat adjusted earnings guidance for the current year after it reported revenue growth for the fourth quarter, powered higher by contributions from its Carelon unit.
The health insurer and healthcare-services provider, formerly known as Anthem, posted a profit of $856 million, or $3.63 a share, compared with $865 million, or $3.59 a share, in the same quarter a year ago.
Stripping out one-time items, including losses on financial instruments and amortization, adjusted earnings were $5.62 a share. Analysts surveyed by FactSet had expected $5.60 a share.
Revenue rose about 7% to $42.45 billion, topping the $42.19 billion that analysts surveyed by FactSet were expecting.
Sales were boosted by higher premium revenue from the health-benefits business and higher pharmacy-product revenue from CarelonRx, lifted in part by the company's acquisition of the BioPlus specialty pharmacy in 2023.
Revenue from the company's health-benefits unit rose more than 4% while its Carelon unit posted revenue gains of 14%.
For 2024, Elevance is targeting adjusted earnings of more than $37.10 a share, above the $37.03 a share that analysts expect. The company is forecasting flat to low-single digit percentage growth in operating revenue.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
January 24, 2024 06:32 ET (11:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?
-
Arm Earnings: Shares Fall as 2025 Guidance Disappoints Investors